Viatris Inc. (VTRS)
Largest Insider Buys in Sector
VTRS Stock Price History Chart
VTRS Stock Performance
About Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system …
Insider Activity of Viatris Inc.
Over the last 12 months, insiders at Viatris Inc. have bought $0 and sold $15.91M worth of Viatris Inc. stock.
On average, over the past 5 years, insiders at Viatris Inc. have bought $558,372 and sold $8.13M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 19 shares for transaction amount of $171 was made by KORMAN HARRY (director) on 2023‑10‑26.
List of Insider Buy and Sell Transactions, Viatris Inc.
| 2024-11-11 | Sale | See Remarks | 26,925 0.0022% | $12.88 | $346,686 | -1.22% | ||
| 2024-09-12 | Sale | director | 200,000 0.0166% | $11.67 | $2.33M | +1.23% | ||
| 2024-08-30 | Sale | director | 50,000 0.0042% | $12.00 | $600,000 | -2.15% | ||
| 2024-08-28 | Sale | director | 50,000 0.0042% | $11.90 | $595,075 | -0.50% | ||
| 2024-08-23 | Sale | director | 100,000 0.0084% | $11.75 | $1.18M | +0.60% | ||
| 2024-08-22 | Sale | director | 100,000 0.0084% | $11.73 | $1.17M | +1.03% | ||
| 2024-08-21 | Sale | director | 100,000 0.0084% | $11.75 | $1.18M | +0.85% | ||
| 2024-06-14 | Sale | director | 264,300 0.0212% | $10.18 | $2.69M | +15.68% | ||
| 2024-06-13 | Sale | director | 85,660 0.0071% | $10.52 | $900,741 | +13.19% | ||
| 2024-05-28 | Sale | Chief Legal Officer | 89,419 0.0075% | $10.38 | $928,429 | +12.91% | ||
| 2024-03-13 | Sale | See Remarks | 250,000 0.0211% | $12.09 | $3.02M | -2.99% | ||
| 2024-03-05 | Sale | See Remarks | 24,353 0.0021% | $12.33 | $300,272 | -4.72% | ||
| 2024-03-05 | Sale | director | 20,000 0.0017% | $12.36 | $247,200 | -4.72% | ||
| 2024-03-04 | Sale | President, Greater China | 21,532 0.0018% | $12.51 | $269,314 | -5.26% | ||
| 2024-02-23 | Sale | See Remarks | 4,000 0.0003% | $13.50 | $54,000 | -13.19% | ||
| 2024-02-15 | Sale | See Remarks | 4,000 0.0003% | $12.50 | $50,000 | -8.35% | ||
| 2024-01-04 | Sale | See Remarks | 4,000 0.0003% | $11.50 | $46,000 | +1.47% | ||
| 2023-12-14 | Sale | See Remarks | 4,000 0.0003% | $10.50 | $42,000 | +12.99% | ||
| 2023-11-24 | Sale | President, Greater China | 14,937 0.0012% | $9.37 | $139,942 | +23.30% | ||
| 2023-10-26 | director | 19 <0.0001% | $9.01 | $171 | +28.59% |
Insider Historical Profitability
| GOETTLER MICHAEL | Chief Executive Officer | 136796 0.0115% | $12.52 | 1 | 0 | +8.94% |
| KORMAN HARRY | director | 94960 0.008% | $12.52 | 10 | 0 | |
| KILTS JAMES M | director | 64905 0.0054% | $12.52 | 1 | 0 | <0.0001% |
| CORNWELL W DON | 22031 0.0018% | $12.52 | 4 | 0 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $1.69B | 11.89 | 141.53M | -0.52% | -$8.82M | 0.03 | |
| BlackRock | $1.11B | 7.84 | 93.33M | +1.08% | +$11.88M | 0.02 | |
| State Street | $749.37M | 5.27 | 62.76M | +1.35% | +$10M | 0.03 | |
| T. Rowe Price | $691.14M | 4.86 | 57.88M | +17.02% | +$100.52M | 0.09 | |
| Davis Selected Advisers | $686.14M | 4.83 | 57.47M | -8.29% | -$62.04M | 3.92 |